Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction

Stem Cells

Volumn 26, Issue 3, 2008, Pages 638-645

  Gandia, Carolina ^a   Arminan A N A ^a   García Verdugo, Jose Manuel ^a,b   Lledó, Elisa ^a   Ruiz, Amparo ^b   Miñana, M Dolores ^c   Sanchez Torrijos, Jorge ^c   Payá, Rafael ^c   Mirabet, Vicente ^d   Carbonell Uberos, Francisco ^d   Llop, Mauro ^a   Montero, Jose Anastasio ^a,e   Sepúlveda, Pilar ^a,c  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d Centro de Transfusion de la Comunidad Valenciana   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Dental pulp stem cells; Left ventricular function; Mesenchymal stem cells; Stem cell therapy; Ventricular remodeling

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTAL PULP STEM CELL; DISEASE MODEL; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HUMAN; HUMAN CELL; MALE; NONHUMAN; RAT; STEM CELL; TOOTH PULP; TREATMENT OUTCOME; ADOLESCENT; ADULT; ANIMAL; BIOLOGICAL THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; ECHOGRAPHY; HEART INFARCTION; HEART MUSCLE CELL; MESENCHYMAL STEM CELL; NUDE RAT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROVIRUS; RETROVIRUS INFECTION; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; TRANSPLANTATION; ULTRASTRUCTURE; VIROLOGY;

ANIMALIA; RATTUS;

ADOLESCENT; ADULT; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DENTAL PULP; HUMANS; MALE; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, NUDE; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE THERAPY; VENTRICULAR FUNCTION, LEFT;

EID: 43049094126     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0484     Document Type: Article

References (38)

1. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
2. Young HE, Steele TA, Bray RA et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001;264:51-62.
3. Su EJ, Cioffi CL, Stefansson S et al. Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization. Am J Physiol Heart Circ Physiol 2003;284:H1429-H1440.
4. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. STEM CELLS 2003;21:105-110.
5. Yen BL, Huang HI, Chien CC et al. Isolation of multipotent cells from human term placenta. STEM CELLS 2005;23:3-9.
6. Gronthos SMM, Brahim J, Robey PG et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 2000;97:13625-13630.
7. Kern S, Eichler H, Stoeve J et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. STEM CELLS 2006;24:1294-1301.
8. Liechty KW, MacKenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-1286.
9. Davani S, Marandin A, Mersin N et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003;108(suppl 1):II253-II258.
10. Dai W, Hale SL, Martin BJ et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short- and long-term effects. Circulation 2005;112:214-223.
11. Nagaya N, Kangawa K, Itoh T et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-1135.
12. Wang JS, Shum-Tim D, Galipeau J et al. Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 2000;120:999-1005.
13. Shi S, Robey PG, Gronthos S. Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. Bone 2001;29:532-539.
14. Yamada Y, Fujimoto A, Ito A et al. Cluster analysis and gene expression profiles: A cDNA microarray system-based comparison between human dental pulp stem cells (hDPSCs) and human mesenchymal stem cells (hMSCs) for tissue engineering cell therapy. Biomaterials 2006;27:3766-3781.
15. Pierdomenico L, Bonsi L, Calvitti M et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 2005;80:836-842.
16. Matsushita K, Motani R, Sakuta T et al. The role of vascular endothelial growth factor in human dental pulp cells: Induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res 2000;79:1596-1603.
17. Artese L, Rubini C, Ferrero G et al. Vascular endothelial growth factor (VEGF) expression in healthy and inflamed human dental pulps. J Endod 2002;28:20-23.
18. Tran-Hung L, Mathieu S, About I. Role of human pulp fibroblasts in angiogenesis. J Dent Res 2006;85:819-823.
19. Caviedes-Bucheli J, Munoz HR, Rodriguez CE et al. Expression of insulin-like growth factor-1 receptor in human pulp tissue. J Endod 2004;30:767-769.
20. Reichenmiller KM, Mattern C, Ranke MB et al. IGFs, IGFBPs, IGF-binding sites and biochemical markers of bone metabolism during differentiation in human pulp fibroblasts. Horm Res 2004;62:33-39.
21. Sawa Y, Horie Y, Yamaoka Y et al. Production of colony-stimulating factor in human dental pulp fibroblasts. J Dent Res 2003;82:96-100.
22. Gagari E, Rand MK, Tayari L et al. Expression of stem cell factor and its receptor, c-kit, in human oral mesenchymal cells. Eur J Oral Sci 2006;114:409-415.
23. Duerr RL, Huang S, Miraliakbar HR et al. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-627.
24. Aikawa R, Nawano M, Gu Y et al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000;102:2873-2879.
25. Friedrich J, Apstein CS, Ingwall JS. 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart. Circulation 1995;92:3527-3538.
26. Agbulut O, Vandervelde S, Al Attar N et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004;44:458-463.
27. Litwin SE, Katz SE, Morgan JP et al. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994;89:345-354.
28. Tomasek JJ, Gabbiani G, Hinz B et al. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3:349-363.
29. Wang J, Chen H, Seth A et al. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2003;285:H1871-H1881.
30. Fazel S, Cimini M, Chen L et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-1877.
31. Miyahara YNN, Kataoka M, Yanagawa B et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
32. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
33. Noiseux N, Gnecchi M, Lopez-Ilasaca M et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006;14:840-850.
34. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661-669.
35. Uemura R, Xu M, Ahmad N et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006;98:1414-1421.
36. Chien KR. Lost and found: Cardiac stem cell therapy revisited. J Clin Invest 2006;116:1838-1840.
37. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-685.
38. Dawn B, Guo Y, Rezazadeh A et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006;98:1098-1105.